WALKER KAREN MARIE (Chief Technology Officer) received a stock award from KYVERNA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/15/2025ACC: 0000950170-25-054342
Officer· Chief Technology Officer
Since Feb 2024
+93K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
93K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13K
Price / share
—
Trade value
—
% of position
134.9%
4/11/2025
9.64K→22.64K
Total
Net shares
+13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/11/2025 | A · Award | +13K | — | — | 134.9% | 9.64K | 22.64K |
| Total | +13K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
80K shares
Shares
+80K
Strike price
2.06
Held after
80K
Exercisable
—
4/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock80K shares | 4/11/2024 | A · Award | +80K | 2.06 | — | 80K |